The Europe Nerve Repair and Regeneration Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
The proximal and distal axon stumps, the nerve cell body, and neurotropic, neuritepromoting (NPF), and matrix factors all play a role in peripheral nerve regeneration. The neuronal cell body in the spinal cord swells, the Nissl bodies begin to degenerate (chromatolysis), and the nucleus starts moving to the periphery as the metabolic priority shifts from neurotransmitter synthesis to the development of parts needed for axonal growth and elongation shortly after nerve injury.
Surgery is changing from a field that focuses largely on the repair or replacing damaged or diseased tissues to one that focuses on the rejuvenation of ageing tissues and the rebuilding of tissues or organs with scar-free healing. Excellent clinical skills, technical ability to perform precision and minimally invasive procedures with laptop navigation, and microsurgical manipulation, as well as a working knowledge of molecular biology, biological engineering, and stem cell science, would be required of future surgeons.
Alzheimer's disease is expected to affect 5.05 percent of Europeans. The prevalence was 3.31 percent in men and 7.13 percent in women, and it rose with age. Alzheimer's disease had an incidence of 11.08 per 1000 person-years in Europe. Men had a rate of 7.02 per 1000 person-years, while women had a rate of 13.25 per 1000 person-years; both rates increased with age. This creates lucrative opportunities for the regional market players.
Sweden is among the best and most sophisticated healthcare systems in the world. Overall, the population of ten million people is in excellent health. Sweden spends roughly 11% of its GDP on health and medical services, which is comparable to the majority of other European countries. Because Sweden has one of the world's oldest populations (20.37 percent of the population is 65 or over), medical supplies, as well as longer-term medical treatments, will be in higher demand to satisfy the health needs of an ageing population. The expansion in the healthcare sector of Europe is among the key factors bolstering the demand for innovative medical solutions for various diseases. Along with that, governments across this region are widely investing a huge amount in strengthening the healthcare system and health insurance sector, which would further boost the growth of the regional nerve repair and regeneration market over the forecast period.
The Germany market dominated the Europe Nerve Repair and Regeneration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $601.4 Million by 2028. The UK market is poised to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The France market would display a CAGR of 7% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Nerve Repair and Regeneration Market Size will Hit $9.4 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
By Surgery
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 